851822_App1_online_supp – Supplemental material for Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study Yazid N. Al Hamarneh Karissa Johnston Carlo A. Marra Ross T. Tsuyuki 10.25384/SAGE.8273666.v1 https://sage.figshare.com/articles/journal_contribution/851822_App1_online_supp_Supplemental_material_for_Pharmacist_prescribing_and_care_improves_cardiovascular_risk_but_is_it_cost-effective_A_cost-effectiveness_analysis_of_the_RxEACH_study/8273666 <p>Supplemental material, 851822_App1_online_supp for Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study by Yazid N. Al Hamarneh, Karissa Johnston, Carlo A. Marra and Ross T. Tsuyuki in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada</p> 2019-06-10 12:00:00 pharmacist intervention Markov cost-effectiveness model CV events 30 years risk assessment equations R x EACH study Background CV risk reduction R x EACH health outcomes R x EACH randomized trial Canadian health care system